Results 81 to 90 of about 2,720 (100)

[Radix codonopsis combined with Poria improves cognitive impairment in rats with unilateral common carotid artery ligation by regulating the ERα/PI3K/Akt signaling pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Yang J, He Y, Guo Y, Shang F, Hua L, Yang Y, Zhang X, Wei J.   +7 more
europepmc   +1 more source

[Recent advances in the management of iron deficiency and iron deficiency anemia during pregnancy]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang J, Chen M.
europepmc   +1 more source

[Chinese expert consensus on the use of standardized second-line drugs for primary hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Translational Medicine Branch, China Association of Gerontology and Geriatrics, Society of Hepatology, Beijing Medical Association, Expert Committee on Liver Cancer, Chinese Society of Clinical Oncology.   +5 more
europepmc   +1 more source

[How I treat acquired clotting factor deficiency]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang L, Gu WJ.
europepmc   +1 more source

[Research Progress on Microbiome-Driven Mechanisms and Intervention Strategies for Oral Malodor]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Shang X, Wang Z, Ge S.
europepmc   +1 more source

[Metabolomics study on anti-inflammatory effects of Guanjie Zhentong Babu plaster in collagen-induced arthritis rats]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Xu T, Xu J, Yang X, Shi R, Ni L.
europepmc   +1 more source

[Cytotoxic effects of the novel photosensitizer PEG<b>-</b>MTPABZ<b>-</b>PyC<b>-</b>mediated photodynamic therapy on gastric cancer cells]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Chen L, Wang Q, Wang L, Shen Y, Wang H, Wang H, Su X, Lei M, Chen X, Ai C, Li Y, Zhou Y.   +11 more
europepmc   +1 more source

[Data mining and toxicity profile analysis of immune checkpoint inhibitor-related skin toxicity events based on FAERS]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Ma S, Li M, Ren Y, Wang X.
europepmc   +1 more source

[Efficacy and safety of venetoclax combined with tyrosine kinase inhibitors and reduced-dose chemotherapy in 13 cases of minimal residual disease-positive and relapsed/refractory Ph(+) acute lymphoblastic leukemia]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Ai H, Liang TT, Wang Q, Wu HF, Yin QS.
europepmc   +1 more source

[Expert recommendations on the management of adverse reactions in pegylated interferon alpha therapy for chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Expert Group on the Management of Adverse Reactions in Pegylated Interferon Alpha Therapy for Chronic Hepatitis B.
europepmc   +1 more source